Skip to content

Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

Pericardiotomy for Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery in China

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06728826
Acronym
PRINCE-CH
Enrollment
650
Registered
2024-12-11
Start date
2025-12-01
Completion date
2027-06-30
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF), Cardiac Events, Pericardial Effusion

Keywords

Pericardiotomy, Atrial Fibrillation

Brief summary

PRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.

Detailed description

Postoperative atrial fibrillation (POAF), defined as new-onset atrial fibrillation (AF) in the immediate period after surgery, is the most important type of secondary AF, which complicates 20-40% patients receiving cardiac surgery. POAF is associated with haemodynamic instability , increased risk of stroke, lengthened hospital and intensive care unit stays and greater costs. Pericardial effusion accumulated posterior to the left atrium after cardiac surgery could trigger atrial arrhythmias. Pericardiotomy allows for prolonged drainage of the pericardial effusion into left pleural space. Recent research evidence found that pericardiotomy was associated with a significantly lower incidence of POAF. The existing data on posterior pericardiotomy is promising for a reduction in POAF. The PRINCE trial's long-term follow-up of patients randomized to pericardiotomy could conclusively demonstrate whether the relationship of POAF to post-discharge clinical outcomes is causal and modifiable. The PRINCE-CH trial will evaluate the effectiveness and safety of pericardiotomy in preventing POAF after cardiac surgery in Chinese population. The intervention is posterior pericardiotomy and the control is no posterior pericardiotomy during cardiac surgery. The primary outcome is the occurrence of POAF. The study will enrol 650 patients from 15 centres in China. All participants will be continuously monitored using a wearable body surface electrocardiogram (EKG) monitoring equipment from the day of surgery to 30 days after surgery.

Interventions

The surgeon will perform a posterior pericardiotomy while the patient is on cardiopulmonary bypass. In detail, a 4-cm opening in the posterior pericardium will be made with a cautery between the left inferior pulmonary vein and the diaphragm. Then a soft channel drain will be placed through the opening in pericardium with the tip into the left pleural space.

Sponsors

Changhai Hospital
Lead SponsorOTHER
The General Hospital of Northern Theater Command
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Each patient will be assigned in a blinded fashion to one of two groups (pericardiotomy or no pericardiotomy) in a 1:1 ratio.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than or equal to 18 years of age * Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries * Able to provide informed consent

Exclusion criteria

* History of atrial fibrillation or flutter * Reoperations/minimally invasive cardiac surgery/emergent presentation * Need for hypothermic circulatory arrest * Disease of the left pleura or previous left thoracotomy * Chest deformity * Unlikely to participate in follow-up assessments

Design outcomes

Primary

MeasureTime frameDescription
Postoperative atrial fibrillationWithin 30 days after index cardiac surgeryNumber of patients with postoperative atrial fibrillation within the 30 days postoperatively

Secondary

MeasureTime frameDescription
Atrial fibrillation burdenWithin 30 days after index cardiac surgeryThe proportion of time spent in atrial fibrillation during the total time of cardiac rhythm monitoring within 30 days after the operation, expressed as a percentage.
Heart rate variabilitywithin 30 days of index surgeryAverage HR(bpm), Highest HR(bpm), Lowest HR(bpm), pNN50(%), rMSSD(ms), SDNN(ms)
Antiarrhythmic drug usewithin 30 days of index surgeryNumber of patients received antiarrhythmic drug to control heart rhythm
Electrical cardioversionwithin 30 days of index surgeryNumber of patients received electrical cardioversion for severe heart arrhythmia
Length of stay in ICUwithin 30 days of index surgeryLength of time in ICU
Duration of hospitalizationwithin 30 days of index surgeryDuration of hospitalization
Hospital readmission or unplanned hospital visitwithin 30 days of index surgeryNumber of hospital readmissions or unplanned hospital visits
Change in Quality of lifewithin 30 days of index surgeryChange in Quality of life assessed by the European quality of life index version 5D (EQ-5D-5L) questionnaire from baseline to 30 days after surgery

Countries

China

Contacts

CONTACTHao Zhang, M.D. Ph.D.
13818178916@163.com86-21-31161765
STUDY_DIRECTORLin Han, M.D. Ph.D.

Naval Medical University Changhai Hospital

STUDY_DIRECTORHuishan Wang, M.D. Ph.D.

The General Hospital of Northern Theater Command

PRINCIPAL_INVESTIGATORHao Zhang, M.D. Ph.D.

Naval Medical University Changhai Hospital

PRINCIPAL_INVESTIGATORYuji Zhang, M.D. Ph.D.

The General Hospital of Northern Theater Command

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026